2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflamm

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514252, 514241, 544298, 544295, 544296, 544238, 544216, C07D23936, A61K 31505

Patent

active

051871750

ABSTRACT:
The present invention is novel compounds which are 2-carbonyl substituted-5-hydroxy-1,3-pyrimidines and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are now found to have activity as inhibitors of 5-lipoxygenase and/or cyclooxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever and the like. Thus, the present invention is also a pharmaceutical composition or method of manufacturing a pharmaceutical composition for the use of treating the noted conditions.

REFERENCES:
patent: 4708966 (1987-11-01), Loomans et al.
patent: 4810716 (1989-03-01), Connor et al.
patent: 4959503 (1990-09-01), Connor et al.
patent: 5077411 (1991-12-01), Connor et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflamm does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflamm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflamm will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2148202

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.